Vaxart Common Stock Shares Outstanding from 2010 to 2024

VXRT Stock  USD 0.61  0.01  1.67%   
Vaxart Common Stock Shares Outstanding yearly trend continues to be comparatively stable with very little volatility. Common Stock Shares Outstanding is likely to outpace its year average in 2024. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
1985-09-30
Previous Quarter
184.7 M
Current Value
227.5 M
Quarterly Volatility
44.7 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaxart financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxart's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 M, Interest Expense of 1.4 M or Total Revenue of 7 M, as well as many indicators such as Price To Sales Ratio of 10.68, Dividend Yield of 0.0 or PTB Ratio of 2.34. Vaxart financial statements analysis is a perfect complement when working with Vaxart Valuation or Volatility modules.
  
Check out the analysis of Vaxart Correlation against competitors.

Latest Vaxart's Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of Vaxart Inc over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Vaxart's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxart's overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

Vaxart Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean45,413,263
Geometric Mean9,164,076
Coefficient Of Variation134.94
Mean Deviation54,299,671
Median3,513,123
Standard Deviation61,279,189
Sample Variance3755.1T
Range151.9M
R-Value0.87
Mean Square Error1005.8T
R-Squared0.75
Significance0.000029
Slope11,876,891
Total Sum of Squares52571.9T

Vaxart Common Stock Shares Outstanding History

2024152.1 M
2023144.8 M
2022127.7 M
2021121.5 M
202088.3 M
201921.6 M
20186.3 M

About Vaxart Financial Statements

Vaxart shareholders use historical fundamental indicators, such as Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although Vaxart investors may analyze each financial statement separately, they are all interrelated. The changes in Vaxart's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vaxart's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding144.8 M152.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.